Shining a Light on Barrier Function.
Journal article
Friedrich M. and Travis S., (2022), Gastroenterology
Is Crohn's Disease a Rightly Used Eponym?
Journal article
Van Hootegem P. and Travis S., (2020), Journal of Crohn's & colitis, 14, 867 - 871
The impact of intestinal transplantation on quality of life
Journal article
Ambrose T. et al, (2020), Clinical Nutrition, 39, 1958 - 1967
Management of pouch-vaginal fistulas - experience from our institution.
Journal article
Sivathondan PC. et al, (2020), Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 22, 439 - 444
Temporary faecal diversion in ileocolic resection for Crohn’s disease: is there an impact on long‐term surgical recurrence?
Journal article
Bolckmans R. et al, (2020), Colorectal Disease, 22, 430 - 438
Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial.
Journal article
Panaccione R. et al, (2020), Gut, 69, 658 - 664
Does Smoking Cessation Reduce Surgical Recurrence After Primary Ileocolic Resection for Crohn's Disease?
Journal article
Bolckmans R. et al, (2020), Diseases of the colon and rectum, 63, 200 - 206
Loss of IL-10 signaling in macrophages limits bacterial killing driven by prostaglandin E2.
Journal article
Mukhopadhyay S. et al, (2020), The Journal of experimental medicine, 217
The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn's Disease: 4 Years of Global Post-marketing Data.
Journal article
Cohen RD. et al, (2020), Journal of Crohn's & colitis, 14, 192 - 204
IM-UNITI at Three Years: Stellar Stelara® or Stardust? The Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
Journal article
Travis S., (2020), Journal of Crohn's & colitis, 14, 1 - 3
Remission of Inflammatory Bowel Disease in Glucose-6-Phosphatase 3 Deficiency by Allogeneic Haematopoietic Stem Cell Transplantation
Journal article
Bolton C. et al, (2020), Journal of Crohn's and Colitis, 14, 142 - 147
Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data.
Journal article
Card T. et al, (2020), Alimentary pharmacology & therapeutics, 51, 149 - 157
Autologous stem cell transplantation in refractory Crohn’s disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study
Journal article
Snowden JA. et al, (2019), BMC Gastroenterology, 19
TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions
Journal article
Leng T. et al, (2019), Cell Reports, 28, 3077 - 3091.e5
Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn's disease patients: the METRIC diagnostic accuracy study.
Journal article
Taylor SA. et al, (2019), Health technology assessment (Winchester, England), 23, 1 - 162
Systems-level analysis of monocyte responses in inflammatory bowel disease identifies IL-10 and IL-1 cytokine networks that regulate IL-23
Journal article
Aschenbrenner D. et al, (2019)
Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysis
Journal article
Walsh A. et al, (2019), Intestinal Research, 17, 365 - 374
Authors’ reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn’s Disease Behavior, Fecal Calprotectin and Quality of Life
Journal article
Bryant RV. et al, (2019), Inflammatory Bowel Diseases, 25, e62 - e63
Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis—a Prospective Analysis
Journal article
Walsh A. et al, (2019), Journal of Crohn's and Colitis, 13, 424 - 430
Visceral Adipose Tissue Is Associated With Stricturing Crohn’s Disease Behavior, Fecal Calprotectin, and Quality of Life
Journal article
Bryant RV. et al, (2019), Inflammatory Bowel Diseases, 25, 592 - 600